Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:14 AM
Ignite Modification Date:
2025-12-25 @ 2:14 AM
NCT ID:
NCT02796560
Eligibility Criteria:
Inclusion Criteria:
* Be apt to give consent
* Have a diagnostic of primary open angle glaucoma or ocular hypertension requiring treatment
Exclusion Criteria:
* Angle closure glaucoma or having benefited from a peripheral iridotomy
* Known allergies to travoprost or to one of the ingredients
* Current usage of other glaucoma drops other than travoprost
* Current usage of topical corticosteroids
* Pregnancy
* Breast feeding
* Monophthalmic
* Having benefited from glaucoma surgery including trabeculectomies, implant drainage devices, and selective laser trabeculectomies
* Active intraocular inflammation
* Ocular surface disease that interferes with accurate measuring of the intraocular pressure
* Any clinically significant ocular disease that could interfere with the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02796560
Study Brief:
Protocol Section:
NCT02796560